We are live on ! Find out more
WEJOW

Wejo Group Limited Warrant

Delisted

WEJOW was delisted on the 8th of June, 2023.

1 hedge funds and large institutions have $25 invested in Wejo Group Limited Warrant in 2023 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 21 (-1)

89% less capital invested

Capital invested by funds: $237 → $25 (-$212)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
MCM
Moore Capital Management
New York
-$210
Name Holding Trade Value Shares
Change
Change in
Stake
AA
1
Ancora Advisors
Ohio
$25
MCM
2
Moore Capital Management
New York
-$210 -100,000 Closed

WEJOW Hedge Fund Activity: Q3 2023 in Review

1 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Wejo Group Limited Warrant (WEJOW) for Q3 2023, worth a combined $25 — down 89% from $237 a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of WEJOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Moore Capital Management, exiting entirely with an estimated $210 sold.

  • 1 institutional investor held Wejo Group Limited Warrant (WEJOW) as of Q3 2023, down from 2 in Q2 2023.
  • Funds reported $25 of Wejo Group Limited Warrant stock for Q3 2023, down 89% quarter-over-quarter.
  • 0 funds opened new Wejo Group Limited Warrant positions in Q3 2023 and 1 closed out, a net change of -1 holder.
  • The largest Wejo Group Limited Warrant seller in Q3 2023 was Moore Capital Management, an estimated $210 sold.

Based on aggregated 13F filings for Q3 2023.